- Alex’s Lemonade Stand: 2024 ‘A’ Award Grant
Amount: $800,000 over 4 year
Deadline: June 16, 2025
Eligibility: Applicants must have an MD, PhD or MD/PhD (DO, MBBS or equivalent) and be within five years of their first faculty appointment as an Assistant Professor at the time that their application is submitted as well as: MD and MD/PhD must be within ten years of their terminal research degree or end of post-graduate clinical training (whichever date is later). PhD must be within ten years of their terminal research degree. More senior Assistant Professors, as well as Associate and Full Professors, are ineligible. If still at the Instructor level, the applicant must have a firm commitment from the Department Chair/Division Chief at the time of grant submission for an Assistant Professor position within one year of receiving the award. A minimum of 75% of the applicant’s time during the ‘A’ Award period must be allocated as non-clinical protected time for all research activities. This percentage of time includes both ‘A’ Award activities and the applicant’s other research responsibilities. Mentor(s) must be identified and must be in the applicant’s home institution. A co-mentor whose research expertise is aligned with the application could be added from an outside institution. Applicants cannot be the Principal Investigator (PI) of a K99/R00 or other independent, nationally competitive award (e.g., R01 or equivalent, P or U award) that has been funded or recommended for funding (i.e., will be funded) any time before the ‘A’ Award grant start date.
About: Supports early career scientists who want to establish a career in pediatric oncology research. The ideal applicant has an original project that is not currently being funded. Demonstration of a future commitment to pediatric cancer investigation as well as institutional support for the career development of the investigator are critical components of a successful application. A mentor is required, and a career development plan must be included. - Rachel Horne Prize for Women’s Research in MS
Amount: $40,000 over 4 year
Deadline: June 16, 2025
Eligibility: Applicants must be an MD, or been awarded a PhD in the past 1-10 years. At the time of submission, the applicant should not hold a higher academic rank than assistant professor level. Applicants should identify as female. There are no specific requirements in respect of residency, citizenship or membership of iWiMS.
About: This international annual prize of US$40,000 recognises a woman scientist for her outstanding contribution to women’s health-related research in multiple sclerosis.
- Alex’s Lemonade Stand Foundation: 2025 R Accelerated Grant
Amount: $800,000 over 1 year
Deadline: June 5, 2025
Eligibility: Applicants must have an MD, PhD, or MD/PhD, DO, MBBS or equivalent and be within ten years of their first faculty appointment at the Assistant Professor level (higher academic ranks allowed) at the time that their application is submitted. Applicants cannot be lead PIs on active ALSF funded grants concurrent with the R Accelerated Award. Applicants must be a PI or co-PI of their first independent award such as R01 and must be within five years of the notice of award. A Notice of Award document from the NIH or other funding organization must be submitted with the application. There must be clear documentation of how scientific and budgetary overlap will be avoided. R01 equivalent NIH awards include the DP1, DP2, DP5, R37, R56, RF1, RL1, U01 and selected R35 activity codes. Applicants with a K99/R00 award are eligible, if the PI is in the R00 phase of the award at the time of submission. Please read the ALSF R01 equivalency policy for more details. Funding from other agencies should be peer-reviewed awards of $200,000 (USD) or more a year for 4 or more years. R01-equivalent grants cannot be mentored-career development awards.
About: The purpose of the R Accelerated Award Grant is to advance ALSF’s mission to find cures and better treatments for childhood cancers by providing support to scientists focused on pediatric oncology research. Applicants must have an original project that is not currently being funded that has a clear focus on accelerating the discovery of more effective, less toxic therapies for childhood cancers. Research projects should address a testable hypothesis based on strong scientific rationale. Demonstration of continued commitment to pediatric cancer investigation as well as institutional support are critical components of a successful application. - 2025 THRIVE Global Impact Challenge
Amount: The winning company will receive the THRIVE Global Impact Challenge Award in addition to investment from SVG Ventures up to $1M USD.
Deadline: May 25, 2025
Eligibility: Applicants should be early-stage startups or entrepreneurs at the seed to Series A stage. We welcome innovative ideas and solutions that have the potential for growth and scalability. We invite applications from around the world. Entrepreneurs and startups from any country or region are encouraged to apply, as we value diverse perspectives and global collaboration. Applicants should demonstrate a clear alignment with one or more of the above summit themes. Solutions should address the specific challenges within these areas and offer innovative approaches for positive impact. Includes showcasing tangible outcomes, data-driven results, or successful implementation of solutions that have positively influenced sustainability, carbon reduction, biodiversity, or other environmental aspects. While not mandatory, we highly value applicants who can demonstrate a proven impact on climate and the environment.
About: - ICRG- 2025 SEED GRANT FOR RESEARCH ON GMBLING DISORDER AND RESPONSIBLE GAMBLING
Amount: $40,000 over 1 year
Deadline: May 16, 2025
Eligibility: Domestic or international, public or private, non-profit or for-profit organizations are eligible to apply for ICRG funding. The Principal Investigator must have a PhD, MD, or other terminal degree. The ICRG encourages early career investigators to apply for a Seed Grant.
About: The International Center for Responsible Gaming (ICRG) offers Seed Grants in support of a variety of research activities, exploring the etiology, prevention and treatment of gambling disorder, and the development and evaluation of responsible gambling strategies, such as: • Pilot and feasibility studies • Secondary analysis of existing data • Small, self-contained research projects • Development of research methodology • Development of new research technology - ICRG- 2025 DISSERTATION GRANT
Amount: $5,000 over 1 year
Deadline: May 16, 2025
Eligibility: Eligible principal investigators (PIs) are doctoral students at the dissertation stage of training with the skills, knowledge, and resources necessary to carry out the proposed research. The applicant must have an approved dissertation proposal (at the time of award), show evidence of high academic performance in the sciences, and demonstrate a commitment to a career as an independent research scientist, physician-scientist, or clinician-scientist (dual-degree training). The applicant must be currently enrolled in a PhD or equivalent research degree program, a formally combined MD/PhD program, or other combined professional/clinical and research doctoral program in the biomedical, behavioral, or clinical sciences.
About: The goal of the Dissertation Grants program is to support doctoral students by providing funding for the costs of dissertation research on gambling. Applications are encouraged from doctoral candidates in a variety of academic disciplines and programs. This program will ultimately facilitate the entry of promising new investigators into the field of gambling research, including gambling disorder, gambling policy, and responsible gambling. This award provides up to one year of support for the completion of the doctoral dissertation research project. Requests for nocost extensions beyond 12 months will be considered - ICRG- RFA FOR RESEARCH ON THE EFFECTS OF ADVERTISING AND MESSAGING IN LOTTERY GAMBLING
Amount: $75,000/per year for two years plus indirect costs
Deadline: May 16, 2025
Eligibility: Domestic or international, public or private, non-profit or for-profit organizations are eligible to apply for ICRG funding. The Principal Investigator (PI) must have a PhD, MD or other comparable terminal degree. Investigators who are not active PIs or Co-PIs on existing ICRG grants are strongly encouraged to apply.
About: The International Center for Responsible Gaming (ICRG) invites investigators to apply for a two-year Large Grant to explore the impact of advertising, promotions, and public awareness messaging on lottery gambling and gambling-related harms. While lottery gambling is one of the most prevalent and widely accepted forms of gambling, there is a critical need to understand how marketing strategies and messaging influence gambling behaviors and treatment engagement. This RFA is designed to support research examining how lottery-specific advertising and messaging contribute to awareness, prevention, and treatment efforts for gambling disorder. The aim is to generate actionable insights to inform responsible advertising practices and public health strategies that minimize harm while encouraging individuals with gambling-related problems to seek help. - Simons Foundation: Pivot Fellowship
Amount: $75,000/per year for two years plus indirect costs
Deadline: May 15, 2025
Eligibility: Fellows and mentors must hold a Ph.D., M.D. or equivalent degree in the natural sciences (astronomy, biology, chemistry, earth sciences, neuroscience and physics), engineering, mathematics, data science or computer science — and all subdisciplines therein — and be faculty at an academic institution or hold an equivalent position. Fellows must demonstrate that the fellowship will take place in a new discipline, distinct from their current field of study, within astronomy, biology, chemistry, earth sciences, neuroscience, physics or mathematics — and all subdisciplines therein. In order to receive the fellowship, fellows must be approved by their institution for a full year of leave. Fellows must not hold any other fellowship that will provide them with salary support during the training year of the Pivot Fellowship.
About: We invite applications for the Pivot Fellowship program that will support researchers with a strong track record of success and achievement in their current field, and a deep interest, curiosity and drive to make contributions to a new discipline. The fellowship will enable today’s brightest minds to apply their talents and expertise to a new field, and will consist of one training year where the fellow will be embedded in a lab of a mentor to learn the new discipline and its culture. Mentorship and support are essential for learning a new discipline and culture. In addition to the qualifications and potential of the applicant, the suitability of the mentor and the environment for mentorship will be strongly considered in the application process. - Pilot Grants to Explore the Use of the American Heart Association Protein Binding Atlas to Discover Novel Protein Interactions
Amount: $100,000 for 1 year
Deadline: May 1, 2025
Eligibility: Must be an AHA Professional Member
About: Proposals are welcomed from researchers with experience in one or more of the following areas: systems biology, network science, medicinal chemistry, protein chemistry, machine learning, artificial intelligence, and molecular biology. Collaborative proposals involving multidisciplinary teams are encouraged. This pilot grant is open to early-stage investigators as well as established researchers exploring new areas of inquiry related to the outlined objectives. - 2025-2026 IFER Graduate Fellowships
Amount: $15,000 annually
Deadline: April 30, 2025
Eligibility: Applicants must be graduate students enrolled in a degree program with at least one year remaining until program completion at the time the fellowship begins. Students whose projects utilize human cell lines, stem cells, computational models, and other non-animal methods in place of animal models are encouraged to apply.
About: IFER Graduate Fellowships support projects that advance the development, validation, or implementation of human-relevant, non-animal methodologies in research, testing, or education. Funding is directed toward innovative scientific methods with the potential to replace animal models while improving scientific outcomes. Special consideration will be giving to proposals demonstrating a strong likelihood of replacing or significantly reducing animal use in research. - HALO: Clinical trial protocols for athletic performance evaluation
Amount: Up to $300,000
Deadline: April 30, 2025
Eligibility: —
About: We are looking for validated clinical trial protocols designed to assess the effectiveness of pre- and post-workout interventions on key athletic performance outcomes. The ultimate goal is to connect with key opinion leaders in the field and establish a research collaboration to implement validated protocols for testing different interventions.The protocol should assess muscular power, strength, endurance, cognition, cardiovascular endurance, and fatigue resistance for pre-workout solutions, while measuring muscle recovery, muscle building, and overall physiological recovery for post-workout solutions. - HALO: Hair loss and/or scalp health assessment
Amount: ~$50,000-250,000 for POC project(s) (tech readiness and milestone dependent) with the potential for follow-on funding.
Deadline: April 30, 2025
Eligibility: —
About: We are seeking a diagnostic tool, system, device, or platform that can assess hair loss and scalp health based on relevant biological readouts (e.g., biomarkers, hair growth, scalp or skin benefit endpoints, stress endpoints, etc.). The solution should be consumer-friendly and allow for repeat measurements to track changes over time, helping to demonstrate our products’ efficacy to consumers. An ideal solution would not only assess hair and scalp health but also guide consumers toward the most suitable products and care routines. However, recognizing that technology may not be there yet, our primary focus is on generating meaningful insights that can inform personalized hair and scalp care, offer early detection/proof points to demonstrate efficacy, and help consumers stay on their regimen. - HALO: Hormone tracking and monitoring
Amount: Hourly rate structure for duration of the engagement, with flexibility to adjust base on deliverables.
Deadline: April 30, 2025
Eligibility: Expertise in developing or utilizing hormone tracking and monitoring methods. Experience in hormone research related to reproductive health, menopause, or endocrine function. Knowledge of endocrine biomarkers and their role in physiological health.
About: We are seeking subject matter experts in hormone monitoring to explore current technologies, research methodologies, and biomarker validation strategies that enable real-time tracking of hormonal fluctuations, with a focus on understanding their implications across life stages and translating this data into actionable health insights. - HALO: Insights and innovation in menopause and perimenopause
Amount: Hourly rate structure for duration of the engagement, with flexibility to adjust base on deliverables.
Deadline: April 30, 2025
Eligibility: Expertise in menopause, perimenopause, or reproductive aging research. Expertise in neuroendocrinology and hormonal regulation or menopause-related physiological changes. Clinical or research background in symptom management, interventions, or patient care related to menopause
About: We are seeking to engage with leading experts to deepen our understanding of the menopause space, focusing on the scientific advancements in symptom management and the technologies shaping product development. By connecting with researchers and clinicians, we aim to identify key gaps in current solutions, explore emerging technologies, and highlight future opportunities that will define the next generation of menopause solutions. - ICRG- TRAVEL GRANT FOR RESEARCHERS
Amount: Up to $1,500
Deadline: Ongoing
Eligibility: Travel Grants are available to scientists who are not more than 10 years beyond their MD, PhD or other terminal degree. The applicant must be the first author of the paper or poster to be presented. Eligible meetings include academic conferences that are not specifically focused on gambling disorder and that employ rigorous peer review in the selection of posters and presentations. Examples include national meetings of The American Psychological Association, The College on Problems of Drug Dependence, The Society for Neuroscience, The American Psychiatric Association and The American Psychopathological Association. Contact Travis Sztainert, Director of Research and Education, if you have questions about the eligibility of a conference (tsztainert@icrg.org). Eligible meetings must be scheduled in 2025 or 2026.
About: Travel Grants are intended to support the participation of post-doctoral investigators at scientific meetings at which they are scheduled to present a paper or a poster on gambling disorder research. Applicants may request up to $1,500 for travel in 2025 or 2026. Funds can be used to support economy air transportation, lodging, ground transportation, meals and early bird conference registration fees. The Principal Investigator may apply for only one Travel Grant per cycle.
Development Office’s Corporate and Foundation (C&F)
The Development Office’s Corporate and Foundation (C&F) Team identified the below funding opportunities. To apply, please contact DevCorpFound@mountsinai.org. The C&F team will help plan, write, and submit your application.
- Myotonic Dystrophy Foundation: Post-Doc and Doctoral Fellows Grant
Amount: Postdoctoral Candidates: $105,000 over 2 years; Doctoral Candidates: $55,000 over 2 years
Deadline: September 5, 2025
Eligibility: Postdoctoral applicants must have a Ph.D., M.D., D.O., or other doctoral degree in their profession from an accredited domestic or foreign institution before an MDF Fellowship award can be activated. The degree must be received within no more than three years before the fellowship period. Doctoral applicants must be enrolled and in good standing in a Ph.D. program at an accredited academic medical center or research institute. By the time of the award, the applicant must have completed two years of a doctoral program.
About: Through this Request for Applications (RFA), the Myotonic Dystrophy Foundation (MDF) seeks to engage new scholars in the field of myotonic dystrophy (DM) to advance understanding of the disease and develop therapies for DM. Through this effort, the MDF intends to fund doctoral and postdoctoral research fellowships for projects that focus on basic, translational, and/or clinical research or care in myotonic dystrophy. Fellowships may be awarded for projects with qualified sponsors in appropriate academic, research institute, or pharmaceutical/biotechnology company environments. Projects may focus on basic, translational, and/or clinical research or care in myotonic dystrophy. - Myotonic Dystrophy Foundation: Early Career Research Grant
Amount: $190,000 over 2 year
Deadline: September 5, 2025
Eligibility: Hold a Doctor of Medicine, Doctor of Philosophy, Doctor of Science, or equivalent degree. The terminal degree must have been received no more than ten years prior to the time of the award
About: The Myotonic Dystrophy Foundation (MDF) is accepting applications for two types of Early Career Scholar awards to support the retention of early career researchers in the DM field. Early Career Scholar – Basic/Translational Science: Supports projects in basic research, translational research, or DM care. Applicants must provide a letter from their chair or clinical chief confirming protected time from teaching. Early Career Scholar – Clinical Research: Supports clinical research projects in DM. Applicants must provide a letter from their chair or clinical chief confirming protected time from clinical duties. Proposals may be submitted for basic, clinical, or applied research directly related to myotonic dystrophy in: Pathogenesis; Molecular basis underlying phenotype differences (Type 1, 2, congenital); Development of diagnostics and biomarkers; Progression/natural history; Identification and validation of drug treatment endpoints; Standards of care and care integration, including nursing, social work, and psychology; Epidemiology, economics, and support services; Therapeutic development, particularly, but not limited to, early-stage projects where success can leverage larger investments. - Angelman Syndrome Foundation
Amount: $200,000 over 2 years
Deadline: August 15, 2025
Eligibility: —-
About: Priority will be given to the following topics: Projects studying or correcting the heterozygous effect of non-UBE3A genes in deletion. Projects studying the potential results of increasing UBE3A after therapies or for some subtypes of AS. Projects studying delivery of therapies and potential for improvement. Symptomatic therapies that impact the daily life of people with Angelman syndrome and their families. - Ira W. DeCamp Foundation (JP Morgan): Community Based Health Care
Amount: Unspecified (average $75,000)
Deadline: July 15, 2025
Eligibility: —-
About: Community Health grants will support community health centers (primarily federally qualified health centers) and select primary care providers in the metropolitan area. - Michelson Prizes: Next Generation Grants
Amount: $150,000 over 1y
Deadline: June 22, 2025
Eligibility: Research proposals must be on the topic of human immunology and vaccine development. Researchers 35 years of age and under are eligible
About: The Michelson Prizes is looking for research proposals on human immunology and vaccine research. The committee will look for research that aims to tackle the current roadblocks to human vaccine development and expand our limited understanding of key immune processes that are fundamental to successful vaccine and immunotherapy development. - Pfizer: Transthyretin Cardiac Amyloidosis Fellowship
Amount: $80,000 over 1 year
Deadline: June 20, 2025
Eligibility: —-
About: Specific Area of Interest for this RFP: It is our intent to support institutions with fellowship programs for Cardiologists or Heart Failure Advanced Practice Providers that have a strong focus on clinical practice, research, and education to further the understanding of ATTR cardiac amyloidosis. Proposals from both established and emerging fellowships will be considered. Preference will be given to programs which have not been selected in the last 3 years or states with underserved populations. - OREF/AAOS Clinical Gaps Research Grant
Amount: $100,000
Deadline: June 17, 2025
Eligibility: —-
About: Solicits investigator-initiated research proposals focused on addressing clinical gaps in healing, repair, or diagnostics through devices, biologics, or technology. Areas of research focus may include translational preclinical or clinical research to preferably include pilot human studies. - LAM Foundation Pilot and Feasibility Grant
Amount: $50,000 over 1 year
Deadline: LOI Due June 16, 2025
Eligibility: An applicant may be a postdoctoral research fellow, postgraduate medical trainee, junior faculty, or established investigator. The LAM Foundation encourages applications from investigators new to LAM research who could contribute their knowledge and expertise.
About: The objective of this grant is to provide funds to encourage the development and testing of new hypotheses and/or new methods in research areas relevant to LAM. The proposed work must be hypothesis generating or hypothesis testing, reflecting innovative approaches to important questions in LAM research or development of novel methods, and providing sufficient preliminary data to justify the Foundation’s support. Results from Pilot and Feasibility Grants should lead to the submission of applications for funding from other agencies (e.g., NIH, DOD TSCRP, ATS, etc.). The award is not intended to support the continuation of programs begun under other granting mechanisms. - LAM Foundation Established Investigator Research Grant
Amount: $150,000 over 3 year
Deadline: LOI Due June 16, 2025
Eligibility: —
About: This grant aims to provide funds to faculty-level investigators to encourage the development of new information that contributes to LAM research priorities. All proposals must be hypothesis generating or hypothesis testing and provide sufficient preliminary data to justify The LAM Foundation’s support. Results from Established Investigator Research Grant should lead to the submission of applications for funding from federal agencies (e.g., NIH, NSF, DOD TSCRP, FDA, etc.). - LAM Foundation Clinical Research Grant
Amount: $150,000 over 3 year
Deadline: LOI Due June 16, 2025
Eligibility: An applicant may be a clinical fellow, clinical instructor, postdoctoral research fellow, postgraduate medical trainee, junior faculty or established investigator.
About: The purpose of this grant is to generate hypothesis-driven, patient-centered research that could improve our understanding of novel therapeutic areas of interest, test interventions or new medical devices, or develop clinical research methodologies. The grant is designed to enable research that has the potential to improve an unmet clinical need relevant to the care of LAM patients. A successful application must be feasible within 3 years and would lead to tangible results, such as larger clinical trials or generate data that could be utilized in a natural history database. - LAM Foundation Francis X. McCormack, MD, Career Development Award
Amount: $180,000 over 3 year
Deadline: LOI Due June 16, 2025
Eligibility: Hold an M.D., Ph.D., or equivalent degrees. Be qualified to conduct a program of original research under the supervision of an experienced LAM investigator (for postdoctoral applicants) or independently (for junior faculty). Have an acceptable research plan for LAM. Have access to institutional resources necessary to conduct the proposed research project. Postdoctoral fellows must be no more than 5 years from receiving their terminal research degree or end of post-graduate clinical training at the time of application. Junior faculty investigators must be less than 5 years in a faculty position. Not have been funded under a The LAM Foundation Career Development Grant in the past.
About: This grant aims to provide support for both postdoctoral research fellows and junior faculty who intend to pursue a career in LAM research. Applicants must indicate a commitment to LAM-related research by focusing 50% of their time on LAM in research or clinical practice. More than 50% of the funds must be used for the PI’s salary support. The balance of the funds may be used for research salaries, fringe benefits, supplies, or animal costs. No overhead or indirect costs are provided. - Alex’s Lemonade Stand: 2024 ‘A’ Award Grant
Amount: $800,000 over 4 year
Deadline: June 16, 2025
Eligibility: Applicants must have an MD, PhD or MD/PhD (DO, MBBS or equivalent) and be within five years of their first faculty appointment as an Assistant Professor at the time that their application is submitted as well as: MD and MD/PhD must be within ten years of their terminal research degree or end of post-graduate clinical training (whichever date is later). PhD must be within ten years of their terminal research degree. More senior Assistant Professors, as well as Associate and Full Professors, are ineligible. If still at the Instructor level, the applicant must have a firm commitment from the Department Chair/Division Chief at the time of grant submission for an Assistant Professor position within one year of receiving the award. A minimum of 75% of the applicant’s time during the ‘A’ Award period must be allocated as non-clinical protected time for all research activities. This percentage of time includes both ‘A’ Award activities and the applicant’s other research responsibilities. Mentor(s) must be identified and must be in the applicant’s home institution. A co-mentor whose research expertise is aligned with the application could be added from an outside institution. Applicants cannot be the Principal Investigator (PI) of a K99/R00 or other independent, nationally competitive award (e.g., R01 or equivalent, P or U award) that has been funded or recommended for funding (i.e., will be funded) any time before the ‘A’ Award grant start date.
About: Supports early career scientists who want to establish a career in pediatric oncology research. The ideal applicant has an original project that is not currently being funded. Demonstration of a future commitment to pediatric cancer investigation as well as institutional support for the career development of the investigator are critical components of a successful application. A mentor is required, and a career development plan must be included. - ASA Foundation Fellowship Research Awards
Amount: $75,000 over 1 year (Eligible for renewal after the initial year)
Deadline: June 15, 2025
Eligibility: Be a citizen or permanent resident of the United States of America or Canada. Have an M.D. or equivalent medical degree. Hold a faculty appointment The application for the Fellowship must be submitted within five years from the time that the applicant has completed their residency or fellowship training. Young investigators who have been awarded an aggregate of $100,000 or more in such direct funding are not eligible to apply.
About: The ASA Foundation Fellowship is a career development award and is meant to support young investigators who have not been awarded an aggregate of $100,000 or more in direct extramural career development and independent grant funding (whether already used, a current grant, or funding committed to start on a future date). - Cures Within Reach: Repurposing Research to Improve Patient Outcomes in Meniere’s Disease and Related Diagnoses – Clinical and Preclinical Projects
Amount: Up to $350,000 for collaborative, multisite clinical trials; Up to $100,000 for translational preclinical studies for this RFP
Deadline: June 13, 2025
Eligibility: Be in Meniere’s disease or other vertigo and hearing loss-related diagnoses such as benign paroxysmal positional vertigo (BPPV), tinnitus, labyrinthitis and vestibular neuritis, and repurpose approved and/or generally recognized as safe drugs, devices or nutraceuticals, either alone or in combination. Repurposed therapies can also be added to current standard of care therapies. Be collaborative, multisite, interventional clinical trials. Have a timeline of no longer than 48 months for clinical trials or 36 months for preclinical studies. Be led either by a previously funded investigator or by an early-stage investigator who has received little or no extramural research funding to date
About: This RFP from CWR is seeking collaborative, multisite clinical repurposing trials to address Meniere’s disease, as well as other related vertigo and hearing loss-related diagnoses, such as benign paroxysmal positional vertigo (BPPV), tinnitus, labyrinthitis and vestibular neuritis, to improve patient outcomes and quality of life. CWR may also accept translational preclinical repurposing studies that are designed to advance repurposed therapies to clinical trials or combination preclinical/clinical studies that together produce robust data for publications, presentations, follow on funding and potential off label use of repurposed therapies. We are interested in generic or proprietary drugs, devices, nutraceuticals or other eligible therapies that could be repurposed to create “new” treatments that 1) reduce the symptoms, progression or incidence of; 2) restore function lost to; or 3) to reduce or eliminate severe side effects from current therapies for Meniere’s disease and/or other vertigo and hearing loss-related diagnoses, thereby improving patient outcomes and quality of life - Hyundai Hope on Wheels Bridge to K Award for NIH K Award Applicants
Amount: $150,000 over 1 year
Deadline: June 13, 2025
Eligibility: Applicants for the Hyundai Bridge2K Award must: hold either an MD or MD/PhD degree; be a Pediatric Oncologist in a pediatric cancer-focused division with a junior faculty position (no higher than Assistant Professor) at a COG member institution; have submitted a pediatric cancer-related K award application (K08, K23, K99/R00) within the past 18 months that was scored but not funded (the 18 months begins at review date)
About: The purpose of the Hyundai Bridge2K Award is to provide seed funding to support the resubmission efforts of strong pediatric cancer-focused grant applications that narrowly missed the pay line at national funding agencies. Ideal candidates are those with NIH K award applications (e.g., K08, K23) that were scored. - CURE Epilepsy: Rare Epilepsy Partnership Award
Amount: $100,000 over 1 year
Deadline: LOI Due June 10, 2025
Eligibility: This award is available to both established and early-career investigators. Established investigators are university faculty at the associate professor level or above, or investigators who hold an equivalent position in a non-university research organization. Early career investigators are defined as a) university faculty at the assistant professor level or hold an equivalent position in a non-university research organization, b) researchers with an appointment as an instructor or research assistant professor, c) post-doctoral fellows with at least three years of post-doctoral experience or d) clinical fellows. Early career investigators must have a mentor committed to advising the applicant.
About: The purpose of this funding opportunity is to stimulate and accelerate discovery on rare epilepsies through the development of necessary research tools, techniques, model systems, and data collection platforms. Applications that are strictly focused on basic research including but not limited to gene discovery, understanding cellular pathways and mechanisms, basic electrophysiology, etc., without a research tool-building component will be given lower priority. This award is not intended to fund research focusing solely on a comorbid condition associated with a rare epilepsy without also seeking to develop tools to understand the causes and treatments for the accompanying seizures. Each award will be co-funded by CURE Epilepsy and one or more of the rare epilepsy advocacy groups (partners). Applications must focus on one or more of the specific rare epilepsies that are represented by each group as well as address CURE Epilepsy’s mission to cure epilepsy. Applications must clearly identify the rare epilepsy(ies) that the research is directed towards. General priority areas for this program include: Development of rare epilepsy-specific cellular models including but not limited to patient-derived stem cells, iPSC lines, 3D organoid models or fused organoid models. Development of appropriate genetic animal models. Development of novel in-vitro or in-vivo assays or techniques, for example, drug screening platforms, to enhance research in a rare epilepsy. Development of research tools and novel techniques to enhance understanding of the cellular, molecular, genetic, and systems-level biology that leads to rare epilepsy, as well as facilitate the investigation of disease-modifying or preventative strategies. Supporting registries to better understand the natural history of one or more rare epilepsies or to look across rare epilepsies to identify common therapeutic targets and/or pathways. Projects utilizing existing registries or databases are allowed and must clearly articulate the specific rare epilepsy that will be studied. The use of registry platforms that ensure patient access to their data and when appropriate integrate with existing data collection platforms to enable data sharing with researchers and patient advocacy groups is strongly encouraged. Use of Electronic Health Record data to better understand the disease burden of rare epilepsy and develop therapeutic strategies. Development of technologies that will accelerate accurate diagnoses for rare epilepsies. An overarching goal of this funding mechanism is to develop resources and data that will be made available to the research community to accelerate research on rare epilepsies. - CURE Epilepsy: Catalyst Award
Amount: $250,000 over 2 year
Deadline: LOI Due June 10, 2025
Eligibility: This award is available to independent researchers at or above the level of Assistant Professor (or equivalent) at universities and non-academic research institutions, including small biotechnology companies, who seek to develop new interventions for epilepsy. Postdoctoral fellows may not apply for this award.
About: The purpose of this funding opportunity is to stimulate and accelerate discovery and development of new, transformative therapies for epilepsy, moving promising, well-supported preclinical and/or clinical research closer to clinical application. The award is intended to support the nimble development of data necessary to attract larger commercialization funding opportunities and is not intended to replace those opportunities. Projects based on novel biological pathways and/or highly differentiated therapeutic approaches which are likely to have a high probability of successfully transitioning to clinical development are strongly encouraged. The award is not intended to fund basic research on the mechanisms underlying epilepsy. Priority areas include: Innovative approaches to prevent, modify and/or arrest the development of acquired epilepsy.; Development of novel approaches to prevent the onset or halt the progression of severe pediatric epilepsies.; New, effective treatments for the >30% of the epilepsy population who are pharmaco-resistant.; Translational or clinical approaches aimed at normalizing sleep disturbances or circadian rhythms to treat seizures.; New approaches, biomarkers, or therapies to predict and/or prevent SUDEP. - Alex’s Lemonade Stand Foundation: 2025 R Accelerated Grant
Amount: $800,000 over 4 year
Deadline: June 5, 2025
Eligibility: Applicants must have an MD, PhD, or MD/PhD, DO, MBBS or equivalent and be within ten years of their first faculty appointment at the Assistant Professor level (higher academic ranks allowed) at the time that their application is submitted. Applicants cannot be lead PIs on active ALSF funded grants concurrent with the R Accelerated Award. Applicants must be a PI or co-PI of their first independent award such as R01 and must be within five years of the notice of award. A Notice of Award document from the NIH or other funding organization must be submitted with the application. There must be clear documentation of how scientific and budgetary overlap will be avoided. R01 equivalent NIH awards include the DP1, DP2, DP5, R37, R56, RF1, RL1, U01 and selected R35 activity codes. Applicants with a K99/R00 award are eligible, if the PI is in the R00 phase of the award at the time of submission. Please read the ALSF R01 equivalency policy for more details. Funding from other agencies should be peer-reviewed awards of $200,000 (USD) or more a year for 4 or more years. R01-equivalent grants cannot be mentored-career development awards.
About: The purpose of the R Accelerated Award Grant is to advance ALSF’s mission to find cures and better treatments for childhood cancers by providing support to scientists focused on pediatric oncology research. Applicants must have an original project that is not currently being funded that has a clear focus on accelerating the discovery of more effective, less toxic therapies for childhood cancers. Research projects should address a testable hypothesis based on strong scientific rationale. Demonstration of continued commitment to pediatric cancer investigation as well as institutional support are critical components of a successful application. - AACR Grant For Innovative Bladder Cancer Research
Amount: $50,000 over 1 year
Deadline: June 5, 2025
Eligibility: Applicants must have a doctoral degree (PhD, MD, MD/PhD, DVM, DVM/PhD, or the equivalent)
About: The inaugural AACR Grant for Innovative Bladder Cancer Research seeks to encourage the development of novel approaches to address bladder cancer. Applications are invited from researchers currently in the field as well as investigators with experience in other areas of cancer or biomedical research who have promising ideas and approaches that can be applied to bladder cancer research. - RWJF: Community-Led Systems Research to Address Systemic Racism
Amount: $200,000 over 1 year
Deadline: June 4, 2025
Eligibility: The applicant organization for this CFP must be a CBO that is actively engaged in serving communities that experience systemic racism.
About: This 2025 call for proposals (CFP) will provide funding for a new cohort of community-led pilot studies to produce new, actionable evidence about how to help medical, social, and public health systems work together to address forms of systemic racism. This CFP focuses specifically on systems alignment (SA) interventions that have the potential to dismantle or disrupt the health effects of systemic racism and to positively affect the health and wellbeing of communities that experience systemic racism. S4A prioritizes SA interventions that, if successful, can be rapidly replicated and spread to many communities and contexts across the U.S. in order to achieve broad national impact. - Kennedy Disease Association: WAITE-GRIFFIN SBMA Fellowship
Amount: $75,000 over 1 years
Deadline: June 2, 2025
Eligibility: Applications are welcome from researchers who are interested in a career in SBMA research and/or patient care. Applicants should be no more than five years from the award of a PhD degree, or no more than five years from the completion of residency/fellowship training for MD or MD/ PhD degrees and be engaged in postdoctoral training. Applicants cannot hold the position of Assistant Professor or higher nor can they have their own laboratory. All applicants must have an established mentor who has a PhD, MD or MD/PhD degree and possesses a well documented history of accomplishments in the field of SBMA research. All mentors must have primary appointments at academic, public or private, non-profit research institutions.
About: KDA believes it is important to support young researchers who are enthusiastic about their work. We believe that by doing so, we will encourage them to include research in SBMA in their future career research plans. The fellowship will provide $75,000 to cover salary/benefits for the applicant for one year, plus an additional $2,000 for travel or education. The awardee is expected to devote at least 70% of their time to SBMA research. Any extra funds may be used for supplies. - Kennedy Disease Association: 2025 SBMA Research Grant
Amount: $100,000 over 2 years
Deadline: June 2, 2025
Eligibility: Applications from junior investigators and from senior post-doctoral fellows are encouraged.
About: The Kennedy’s Disease Association (KDA) is planning to fund one or more research grants this year to further the understanding of the pathological mechanisms or possible treatments for Kennedy’s Disease. The KDA projects that funding for each grant can be up to $100,000 for one year or $50,000 per year for two years. Funding for the second year of a two-year grant is contingent upon a review of progress at the end of the first year. - Tina’s Wish: Rising Star Grant
Amount: $200,000 over 2 years
Deadline: June 2, 2025
Eligibility: Applicants should hold a PhD, MD, or MD, PhD degree. PhD applicants must be in a postdoctoral position or within three (3) years of their first faculty appointment (a non-tenured level position) when the grant begins in January 2026. PhD applicants at the instructor level are eligible to apply if their lab is embedded in a more senior/established lab; PhD applicants at the Instructor level who have an independent lab should review the Team Science Grant (TSG) opportunity. MD or MD, PhD applicants must be at the instructor or assistant professor level (or a similar faculty position) and within three years of starting their first faculty appointment at the time of the estimated award date (January 2026). Note: Clinical or research fellows with dedicated research time for the full two years of the Rising Star Grant funding period (January 2026-December 2027) will also be eligible. Fellows should include a letter of institutional commitment from one’s department chair of at least 75% research time for the Rising Star Grant funding period with their application; dedicated research time can be contingent about receipt of the Rising Star grant. Applicants must have a committed mentor to support the applicant throughout the grant period. One’s mentor does not need to be at the same institution as the applicant, provided that the mentor is committed to a meaningful and productive relationship throughout the grant period. Projects must be innovative and focused on early detection or interception of ovarian cancer. For this funding call, Interception refers to disruption of the oncogenic process during the precursor or precancer state. Research on primary prevention of cancer before the oncogenic process begins is not eligible. The research project for which support is requested should be innovative and not currently funded.
About: Tina’s Wish is committed to supporting early career researchers who bring fresh approaches to the study of the early detection or interception of ovarian cancer. The goal is to assist and support promising researchers in the ovarian cancer field and to encourage them to take risks and develop innovative projects. - Cannonball Kids’ Cancer Foundation: Young Investigator Grant
Amount: $100,000 over 3 year
Deadline: LOI Due June 1, 2025
Eligibility: Have a medical doctoral degree: MD, DO, MD/PhD, or equivalent. Be within 5 years of completing a training fellowship in Pediatric Hematology/Oncology or a closely related discipline that has direct clinical contact with pediatric cancer patients. Hold an academic appointment at the instructor level or higher.
About: The goal of CKc’s Young Investigator Grant is to fund research that is within 2-3 years to translation to a clinical trial or is already associated with a clinical trial, is innovative, focuses on cancers that are either underfunded or under-researched, and provides better quality of life or symptom relief than current treatments. - Cannonball Kids’ Cancer Foundation: Clinical Trial Grant
Amount: $200,000 over 3 year
Deadline: LOI Due June 1, 2025
Eligibility: The PI must have a medical doctoral degree: MD, DO, MD/PhD, or equivalent. The Principal Investigator (PI) for the proposed clinical study must hold an academic appointment at the Assistant Professor level or higher
About: The goal of CKc’s Clinical Trial Grant is to fund trials that are innovative, focus on cancers that are either underfunded or under-researched, and provide better quality of life or symptom relief than current treatments - ACS: Extramural Discovery Science Accelerator Award
Amount: $75,000 over 1 year
Deadline: June 1, 2025
Eligibility: Be an independent investigator with a full-time faculty appointment (or equivalent), at an eligible US institution. Applicants may be at any career stage. Be motivated to commercialize their technology.
About: The intent of the Extramural Discovery Science (EDS) Accelerator Award is to support the commercialization of an ongoing cancer research project and to validate and de-risk technologies. Proposals should address key experiment(s) required to move findings toward commercialization that do not easily fit into traditional grant funding mechanisms. This mechanism is not designed to initiate new projects or develop new directions for an ongoing project. The proposal should be commercially driven with the PI having a plan to license the technology, either to an established company or a start-up if the experiment(s) are successful. Examples of research that align with the focus of this funding initiative include but are not limited to: Dosing, toxicity and/or efficacy testing, Testing of biopsies or other patient samples to correlate clinical outcome, Technologies for healthcare delivery, Accelerator awardees will become part of an entrepreneurial collaborative learning community focused on technology commercialization. Grantees will have access to both educational programming developed by the ACS BrightEdge team and the team itself. - March of Dimes: Basil O’Connor Starter Scholar Research Awards
Amount: $150,000 over 2 years
Deadline: May 30, 2025
Eligibility: MD or MD/PhD applicants should be four to nine years past the last year of clinical training required for medical specialty board certification and must hold a full-time tenure-track faculty position (or equivalent) at their current U. S. based institution. Those who have previously submitted an application to the Basil O’Connor program are not eligible for resubmission.
About: Supports impactful research studies that will advance our translational understanding of, or lead to improved clinical treatment of, any serious medical conditions that affect the health of a woman’s pregnancy or the health of mothers and newborns in the first year postpartum. Reflective of our mission, applications should focus on preterm birth and health equity. They should clearly outline a path from discovery to functional studies to clinical translation, with the eventual goal to cure or greatly mitigate conditions that adversely impact the health of pregnant women and newborns. - 2025 Beyond Celiac Early Career Research Grant Award
Amount: $200,000 over 2 year
Deadline: May 26, 2025
Eligibility: Applicants must have a PhD or MD (or equivalent) and have completed their training (including specialty fellowships) within 10 years of the application deadline. Applicants must hold a full-time position at an academic institution and the research is to be conducted in an academic institution.
About: The award is intended to support a research project focused on translational research, with the potential to advance disease knowledge and accelerate discovery and/or development of treatments for celiac disease. - Tuberous Sclerosis Alliance Research Award
Amount: $150,000 over 2 year
Deadline: LOI Due May 19, 2025
Eligibility: All applicants must have a doctoral-level degree, e.g., MD or PhD or equivalent. All applicants must meet the NIH definition of an early-stage investigator (ESI) as of the LOI due date. Research grant Principal Investigator applicants must be an independent researcher, whether tenure-track faculty, non-tenure track faculty/staff, or an equivalent level at a research institution or company. The TSC Alliance fully supports collaborative projects between co-investigators, but only one investigator may be considered the Principal Investigator for the purpose of applying through the online submission system. Previous recipients of a TSC Research Grant award are not eligible to receive a second Research Grant award. Previous recipients of a TSC Alliance Postdoctoral Fellowship or Biosample Seed Grant are eligible to receive a Research Grant if they meet other eligibility criteria
About: Research grant proposals should address one of the following four high-priority areas: Understanding phenotypic heterogeneity in TSC, i.e., research on genetic, biologic, or environmental factors that might explain why TSC is so different from person to person; Gaining a deeper knowledge of TSC signaling pathways and the cellular consequences of TSC deficiency; Improving TSC disease models, whether cell-based, tissue-based, or animal models; Developing clinical biomarkers or patient-reported outcome measures for TSC, particularly those that assess disease burden or stratify an individual’s risk of progression or developing specific manifestations of TSC. - Tuberous Sclerosis Alliance Postdoctoral Fellowships
Amount: $150,000 over 2 year
Deadline: LOI Due May 19, 2025
Eligibility: All applicants must have a doctoral-level degree, e.g., MD or PhD or equivalent. All applicants must meet the NIH definition of an early-stage investigator (ESI) as of the LOI due date. Postdoctoral fellowship applicants must be working with and mentored by a Sponsor to do research relevant to TSC. The Sponsor must be tenure-track faculty, or an equivalent level at a research institution or company. The trainee applicant is considered the “Principal Investigator” for the purpose of postdoctoral fellowship awards. Postdoctoral fellowship applicants must have been a member of the Sponsor’s laboratory for at least 12 months as of the LOI due date. Previous recipients of a TSC Alliance Postdoctoral Fellowship are not eligible to receive a second TSC Alliance Postdoctoral Fellowship award, but they may be eligible to receive a Research Grant as an independent, early-stage investigator. Previous recipients of a TSC Alliance Biosample Seed Grant are eligible to receive a Postdoctoral Fellowship if they meet other eligibility criteria.
About: Supports any type of basic or translational research relevant to TSC that provides an outstanding opportunity for the trainee’s professional growth. - Oncology Nursing Foundation RE03 General Topic Research Grant
Amount: $50,000
Deadline: Letters of Intent (LOI) Due: May 16, 2025; Full Proposals Due: June 28, 2025
Eligibility: The PI (individual primarily responsible for implementing the proposal and reporting to the Oncology Nursing Foundation) must be a registered oncology nurse actively involved in some aspect of cancer patient care, education, or research. The PI must be doctorally-prepared (only one PI can appear on the grant). At least one member of the research team must have received and completed research study funding of at least $100,000 in a principal investigator capacity, thereby serving as a mentor for the project.
About: Support rigorous scientific oncology nursing research. Research projects may include investigator-initiated research, pilot or feasibility studies, supplements to currently funded projects, or developing a new aspect of a program of research. Funding preference is given to projects that involve nurses in the design and conduct of the research activity and that promote theoretically-based oncology practice. - Oncology Nursing Foundation RE34 Breast Cancer Research Grant
Amount: $50,000
Deadline: Letters of Intent (LOI) Due: May 16, 2025; Full Proposals Due: June 28, 2025
Eligibility: The PI (individual primarily responsible for implementing the proposal and reporting to the Oncology Nursing Foundation) must be a registered oncology nurse actively involved in some aspect of cancer patient care, education, or research. The PI must be doctorally-prepared (only one PI can appear on the grant). At least one member of the research team must have received and completed research study funding of at least $100,000 in a principal investigator capacity, thereby serving as a mentor for the project.
About: Supports rigorous scientific oncology nursing research through a focused research grant. Research projects must be breast cancer-focused. - Oncology Nursing Foundation RE33 General Topic Research Grant
Amount: $100,000
Deadline: Letters of Intent (LOI) Due: May 16, 2025; Full Proposals Due: June 28, 2025
Eligibility: The PI (individual primarily responsible for implementing the proposal and reporting to the Oncology Nursing Foundation) must be a registered oncology nurse actively involved in some aspect of cancer patient care, education, or research. The PI must be doctorally-prepared (only one PI can appear on the grant). The PI must have received and completed at least one research study with a funding level of at least $50,000 as the study PI.
About: Supports rigorous scientific oncology nursing research. Research projects may include investigator-initiated research, pilot or feasibility studies, supplements to currently funded projects, or developing a new aspect of a program of research. Funding preference is given to projects that involve nurses in the design and conduct of the research activity and that promote theoretically-based oncology practice. - Oncology Nursing Foundation RE26 Oral Chemotherapy Adherence Research Grant
Amount: $100,000
Deadline: Letters of Intent (LOI) Due: May 16, 2025; Full Proposals Due: June 28, 2025
Eligibility: The PI (individual primarily responsible for implementing the proposal and reporting to the Oncology Nursing Foundation) must be a registered oncology nurse actively involved in some aspect of cancer patient care, education, or research. The PI must be doctorally-prepared (only one PI can appear on the grant). The PI must have received and completed at least one research study with a funding level of at least $50,000 as the study PI.
About: Support rigorous scientific oncology nursing research through a major-focused grant. Research projects must address oral chemotherapy adherence. - International Center for Responsible Gaming (ICRG): 2025 SEED GRANT
Amount: $40,000 over 1 years
Deadline: May 16, 2025
Eligibility: The Principal Investigator (PI) must have a PhD, MD or other comparable terminal degree
About: The International Center for Responsible Gaming (ICRG) offers Seed Grants in support of a variety of research activities, exploring the etiology, prevention and treatment of gambling disorder, and the development and evaluation of responsible gambling strategies, such as: Pilot and feasibility studies; Secondary analysis of existing data; Small, self-contained research projects; Development of research methodology; Development of new research technology - International Center for Responsible Gaming (ICRG): Research on the Effects of Advertising and Messaging in Lottery Gambling
Amount: Up to $187,500 over 2 years
Deadline: May 16, 2025
Eligibility: The Principal Investigator (PI) must have a PhD, MD or other comparable terminal degree
About: This RFA is designed to support research examining how lottery-specific advertising and messaging contribute to awareness, prevention, and treatment efforts for gambling disorder. The aim is to generate actionable insights to inform responsible advertising practices and public health strategies that minimize harm while encouraging individuals with gambling-related problems to seek help. - Alliance for Cancer Gene Therapy: 2025 Investigator Award in Cell and Gene Therapy for Gynecological Cancer Research
Amount: Up to $500,000 over 3y
Deadline: LOI due May 16, 2025
Eligibility: must hold an MD, PhD, or equivalent degree and must be tenure-track or tenured faculty.
About: This new grant award is for those conducting cell and gene therapy research specifically in gynecological cancers (ovarian, endometrial, cervical) - 2025 ACGT – Cinelli Family Foundation Investigator Award in Cell and Gene Therapy for Breast Cancer
Amount: Up to $500,000 over 3y
Deadline: LOI due May 16, 2025
Eligibility: must hold an MD, PhD, or equivalent degree and must be tenure-track or tenured faculty.
About: This new grant award is for those conducting cell and gene therapy research specifically in breast cancers - Gerber Foundation: Pediatric Research Grants
Amount: Up to $350,000 over 3y
Deadline: LOI due May 15, 2025
Eligibility: —-
About: The Foundation’s mission focuses on infants and young children. Accordingly, priority is given to projects that improve the nutrition, care and development of infants and young children from the first year before birth to three years of age. The Foundation is particularly interested in fresh approaches to solving common, everyday problems or emerging issues within our defined focus area. Projects should focus on issues faced by care providers that, when implemented, will improve the health, nutrition and/or developmental outcomes for infants and young children. The board is particularly looking for practical solutions that can be easily and rapidly implemented on a broad scale with a predictable time frame to clinical application. Major Focus Areas: Pediatric Health; Pediatric Nutrition; Environmental Hazards (Nutrient Competitors) - Cystic Fibrosis Foundation 2025 Spring Research Grant
Amount: Up to $450,000 over 3 years
Deadline: May 15, 2025
Eligibility: Applicants must be independent investigators.
About: Research Grants are intended to support efforts that will improve our understanding of disease pathogenesis, such as defects in airway defense, microbial adaption to the CF lung, mucociliary clearance and airway hydration, and extrapulmonary manifestations of the disease. - March of Dimes: Reproductive Scientist Development Program
Amount: $250,000 over 2 years
Deadline: LOI Due May 15, 2025
Eligibility: MD/DO degree and OB/GYN residents near completion of residency or near completion of subspecialty fellowship
About: Due to its focus on young scientists who may not have had rigorous experience or training in scientific inquiry or publication, recipient acceptance into the program does not imply a need to conduct and publish novel, breakthrough scientific work in the OB/GYN space, as this in and of itself is rare. Rather, the program is a March of Dimes effort to recognize and strengthen the wide breadth of human talent in the OB/GYN field and spark a lifelong confidence, passion and commitment to maternal fetal health research that will undoubtedly change not only clinical outcomes, but lives, in the decades to come. As such, research proposals must be translational in nature and relate to the field of maternal fetal health – with a focus on prematurity, maternal and infant morbidity and mortality and health equity – but the outcome of the work is less important than the training and shaping of the recipient during the grant period. - AACR-ALK Positive Lung Cancer Research Fellowship
Amount: $130,000 over 2 year
Deadline: May 15, 2025
Eligibility: Applicants must have a doctoral degree (PhD, MD, MD/PhD, or equivalent) in a related field and not currently be a candidate for a further doctoral degree. Have completed their most recent doctoral degree within the past five years
About: The AACR-ALK Positive Lung Cancer Research Fellowship represents a joint effort designed to encourage and support a postdoctoral or clinical research fellow in conducting ALK-positive lung cancer research and help the grantee establish a successful career path in this field. - National MS Society: Career Transition Fellowships
Amount: $600,000 over 5 year
Deadline: Pre-application May 14, 2025
Eligibility: Applicants must hold a doctoral degree (M.D., Ph.D. or equivalent) and must be in a research oriented postdoctoral training program. Individuals with less than two or more than five years of postdoctoral research experience at the time of application are ineligible for this award. The recipient of this fellowship must secure a faculty position at a research institution prior to completion of the two-year advanced training period.
About: The Career Transition Fellowships targets current postdoctoral trainees who demonstrate both commitment and exceptional potential to conduct MS-related research. The award provides funding over five years to support a two-year period of advanced postdoctoral training in MS research and the first three years of research support in a new faculty appointment. - PCORI: Addressing Violence and Trauma
Amount: Up to $12M over 5 years
Deadline: LOI due May 13, 2025
Eligibility: —
About: PCORI is interested in patient-centered CER of clinical interventions and health system strategies that focus on community-based and hospital-based interventions to address violence and trauma. Of note, studies with an intervention arm that solely involves utilization of a community health worker (CHW) or a patient navigator will be considered non-responsive; however, it will be acceptable to embed CHW outreach or patient navigation into patient-centered CER study questions that address social needs and integrate these professionals as part of a broader organizational intervention strategy for violence and trauma. PCORI is particularly interested in submissions that address the following Special Areas of Emphasis (SAE). The purpose of identifying these SAEs is to encourage submissions to these areas, not to limit submissions to these topics. Applicants addressing one of the below SAEs should identify the area that is best associated with their research approach: Intentional Trauma Applications responsive to this SAE must focus on addressing intimate partner violence, abuse of children and youth or abuse of older adults Unintentional Trauma Must focus on populations with traumatic brain injury (TBI) or on care models for fall prevention and fall recovery among older adults or address impaired mobility and physical function due to unintentional trauma. Substance Use and Trauma Studies must compare existing strategies for pain management aimed at reducing susceptibility to substance use disorder (SUD) in the context of traumatic injury treatment. - Association for Frontotemporal Degeneration: FTD Biomarkers Initiative
Amount: $700,000 over 2 year
Deadline: May 9, 2025
Eligibility: Postdoctoral researchers cannot apply as the lead PI but can be key personnel on a project team.
About: Eligible research proposals include, but are not limited to: Identification of novel biomarkers (e.g., molecular, imaging) for FTLD in human biological samples such as blood, CSF, saliva, or tissues. − Evaluation or development of low-cost screening biomarkers that could identify individuals in need of evaluation by a neurologist due FTD − Evaluation or development of a biomarker that could aid in differential diagnosis of FTLD, either distinct forms of FTLD or comparing FTLD to other causes of neurological symptoms. − Replication studies to validate the utility and reliability of identified human biomarkers. − Development of standardized assays or protocols to quantify biomarker levels. Request for Proposals: FTD Biomarker Initiative – 3 − Translation of biomarkers into clinically applicable diagnostic tools. − Integration of multi-modal approaches (e.g., combining imaging and molecular data) to enhance diagnostic accuracy. - Pulmonary Hypertension Association’s Innovation Research Award
Amount: $120,000 over 2 year
Deadline: May 7, 2025
Eligibility: The applicants must have a post-baccalaureate Ph.D. degree or equivalent, or a doctoral- level clinical degree such as MD, DO, PharmD or Ph.D. in public health or other clinical health sciences and have complete all fellowship or post-doctoral training. Diverse research teams are encouraged to bring together and capitalize on innovative ideas from different perspectives, experiences, and backgrounds.
About: The purpose of the Pulmonary Hypertension Association’s Innovation Research Award is to support highly meritorious, innovative research that could have a great impact towards accelerating the field of pulmonary hypertension research. Any areas of innovative pulmonary hypertension (PH) research will be accepted. Areas of focus include but are not limited to: Novel in vitro or in vivo models of PH; Unique approaches for leveraging PH biorepositories or clinical databases or registries; Novel clinical trial endpoints or outcomes to support PH clinical trials New pathways or mechanisms of action for PH; Studies that address global health burdens. - William T. Grant Foundation: Research Grants on Reducing Inequality
Amount: $600,000 over 3 year
Deadline: May 7, 2025
Eligibility: The Foundation defers to the applying organization’s criteria for who is eligible to act as a Principal Investigator or Co-Principal Investigator on a grant. In general, we expect that all investigators will have the experience and skills to carry out the proposed work. We strive to support a diverse group of researchers in terms of race, ethnicity, gender, and seniority, and we encourage research projects led by Black or African American, Indigenous, Latinx, and/or Asian or Pacific Islander American researchers.
About: Research grants on reducing inequality fund research studies that aim to build, test, or increase understanding of programs, policies, or practices to reduce inequality in the academic, social, behavioral, or economic outcomes of young people ages 5-25 in the United States. We prioritize studies that aim to reduce inequalities that exist along dimensions of race, ethnicity, economic standing, sexual or gender minority status, language minority status, or immigrant origins. We invite studies from a range of disciplines, fields, and methods, and we encourage investigations into various youth-serving systems, including justice, housing, child welfare, mental health, and education. Applications for research grants on reducing inequality must: 1. Identify a specific inequality in youth outcomes. 2. Make a convincing case for the dimension(s) of inequality the study will address. 3. Articulate how findings from your research will help build, test, or increase understanding of a program, policy, or practice to reduce the specific inequality that you have identified. - Prostate Cancer Foundation: 2025 PCF Challenge Awards For Metastatic, Lethal Prostate Cancer
Amount: $1,000,000 over 2 year
Deadline: LOI Due May 5, 2025
Eligibility: Composed of a team of at least three investigators from non-profit academic research centers, including one young investigator. The young investigator may hold the title of Postdoctoral Fellow, Instructor, Research Associate, Assistant Professor, or equivalent and must be within six- years following completion of a professional degree or subsequent mentored academic or clinical training program, such as a postdoctoral or clinical fellowship. He or she should not have been granted commitments for more than $2,000,000 in direct research funding from all sources including institutional funds. Teams may be assembled from one institution or several institutions. Clinical trial direct costs are not allowed; however, correlative research to support high-impact clinical trials for advanced prostate cancer is encouraged. All studies involving patients must include plans for including diverse participant populations with appropriate representation of ethnic and racial minority groups.
About: For investigations of metastatic, lethal prostate cancer. These awards will be funded depending on the level of innovation in applications received. PCF seeks high-risk, currently unfunded projects from academic institutions around the world. Research in the below topic areas are solicited: Theranostics.; Drugging currently undruggable oncology targets: preventing progression to lethal disease.; Improved biotechnologies for precision medicine.; First-in-field immunotherapies for prostate cancer.; Artificial intelligence/machine learning to better inform patient outcomes.; Host microbiome and tumor metabolism. - The Mark Foundation for Cancer Research: Emerging Leader Award
Amount: $750,000 over 3 years
Deadline: LOI due May 5, 2025
Eligibility: MD, PhD, or equivalent is required. Applicants must be employed by a U.S. or Canadian non-profit academic institution. Applicants must be three to eight years from the start of an independent faculty research appointment as of December 31, 2025 (i.e., the official start date of the appointment must fall within the calendar years 2017-2022). Exceptions due to prolonged medical or family leave will be considered on a case-by-case basis. This award is not intended to be the main source of funding for the applicant’s laboratory. Applicants must demonstrate multi-year independent funding that sustains the central activities of the laboratory (e.g., at least one or two grants such as NIH/R01, NSF/CAREER, or equivalently substantial multi-year awards). Individual eligibility will be determined during the review process. Projects for this award must be centered on evidence-based laboratory, data, and/or medical science.
About: Supports innovative cancer research from the next generation of leaders. These grants are awarded to outstanding early career investigators to support high-impact, high-risk projects that are distinct from their current research portfolio. - SENS Research Foundation
Amount: Typical grant amounts are $50K-300K range for 1-3 years, but there is no minimum or maximum funding level restriction.
Deadline: LOI: May 1, 2025
Eligibility: SRF typically does not cover indirect costs. Will not fund proposals for early discovery- or curiosity-driven basic research, or for descriptive studies.
About: SRF regularly funds external research with potential to accelerate the development of rejuvenation biotechnology. Applicants for financial support will be expected to clearly indicate the specific SENS target(s) addressed and explain how their proposed research would further progress toward therapies that remove, repair, replace, or render harmless that target. Only funds proposals with a clear and direct path toward a clearly-conceived, translatable medical intervention for use against the degenerative aging process in humans. - ASH Fellow Scholar Award
Amount: $100,000 over 3 year
Deadline: LOI Due May 1, 2025
Eligibility: Applicants must be in mentored, postdoctoral training positions to be eligible to apply for a Scholar Award. MD/DO applicants should have more than 3 years and 5 or fewer years of research experience after completion of their MD/DO (including research performed during fellowship but excluding clinical fellowship time). PhD or MD/DO-PhD applicants must have 5 or fewer years of research experience after completion of their terminal doctoral degree. (including research performed during fellowship but excluding clinical fellowship time). Applicants who hold independent faculty level positions (Assistant Professor, or equivalent – which may be indicated by having achieved the appointment after an external search and/or if the individual has voting rights as a member of the faculty) must apply for the Junior Faculty Award, regardless of research experience. Individuals serving as an ‘acting’ faculty member may be excluded from this requirement. Be a US or Canadian citizen conducting research anywhere in the world; or hold a visa or permanent resident status in the US or Canada with plans to conduct research within the US or Canada. Be an ASH member in good standing at the time of the letter of intent deadline and plan to maintain membership for the duration of the award term. Have confirmation from the applicant’s institution that at least 75 percent of the applicant’s full-time professional effort is devoted to research. If you have successfully competed for a substantial award (e.g. NIH R01 or equivalent grant) as the PI or co-PI before the application (not LOI) deadline, you are no longer eligible for the Scholar Award. For guidance on what constitutes the scope of a substantial award, see the descriptions of such awards in the NIH Early Stage Investigator (ESI) program. Your primary mentor may be the primary mentor to one applicant per level/category (for example, one basic/translational fellow, one clinical fellow, one basic/translational junior faculty etc.)
About: Since 1985, the ASH Scholar Award has helped ease the transition between training and the establishment of an independent career in hematology research by providing partial salary or other support during that critical period. - ASH Fellow to Faculty Scholar Award
Amount: $125,000 over 2-3 year
Deadline: LOI Due May 1, 2025
Eligibility: Applicants must be in mentored, postdoctoral training positions to be eligible to apply for a Fellow to Faculty Scholar Award. MD/DO, PhD or MD/DO-PhD applicants must have more than 5 years and 8 or fewer years of research experience after completion of their terminal doctoral degree (including research performed during fellowship but excluding clinical fellowship time). At the time of award acceptance, applicants must have available no more than $150,000 annually in research funding, not including the applicant’s salary/fringe or funding from within the institution. Applicants that have completed a Fellow Scholar Award but have five or fewer years (60 months) research experience are eligible to apply for the Fellow to Faculty Scholar Award. Applicants who hold independent faculty level positions (Assistant Professor, or equivalent – which may be indicated by having achieved the appointment after an external search and/or if the individual has voting rights as a member of the faculty) must apply for the Junior Faculty Award, regardless of research experience. Individuals serving as an ‘acting’ faculty member may be excluded from this requirement. Be a US or Canadian citizen conducting research anywhere in the world; or hold a visa or permanent resident status in the US or Canada with plans to conduct research within the US or Canada. Be an ASH member in good standing at the time of the letter of intent deadline and plan to maintain membership for the duration of the award term. Have confirmation from the applicant’s institution that at least 75 percent of the applicant’s full-time professional effort is devoted to research. If you have successfully competed for a substantial award (e.g. NIH R01 or equivalent grant) as the PI or co-PI before the application (not LOI) deadline, you are no longer eligible for the Scholar Award. For guidance on what constitutes the scope of a substantial award, see the descriptions of such awards in the NIH Early Stage Investigator (ESI) program. Your primary mentor may be the primary mentor to one applicant per level/category (for example, one basic/translational fellow, one clinical fellow, one basic/translational junior faculty etc.)
About: Since 1985, the ASH Scholar Award has helped ease the transition between training and the establishment of an independent career in hematology research by providing partial salary or other support during that critical period. - ASH Junior Faculty Scholar Award
Amount: $150,000 over 2-3 year
Deadline: LOI Due May 1, 2025
Eligibility: MD/DO, PhD or MD/DO-PhD applicants must have more than 8 years and 13 or fewer years of research experience after completion of their terminal doctoral degree (including research performed during fellowship but excluding clinical fellowship time). Applicants who hold independent faculty level positions (Assistant Professor, or equivalent – which may be indicated by having achieved the appointment after an external search and/or if the individual has voting rights as a member of the faculty) must apply for the Junior Faculty Award, regardless of research experience. Individuals serving as an ‘acting’ faculty member may be excluded from this requirement. Be a US or Canadian citizen conducting research anywhere in the world; or hold a visa or permanent resident status in the US or Canada with plans to conduct research within the US or Canada. Be an ASH member in good standing at the time of the letter of intent deadline and plan to maintain membership for the duration of the award term. Have confirmation from the applicant’s institution that at least 75 percent of the applicant’s full-time professional effort is devoted to research. If you have successfully competed for a substantial award (e.g. NIH R01 or equivalent grant) as the PI or co-PI before the application (not LOI) deadline, you are no longer eligible for the Scholar Award. Your primary mentor may be the primary mentor to one applicant per level/category (for example, one basic/translational fellow, one clinical fellow, one basic/translational junior faculty etc.)
About: Since 1985, the ASH Scholar Award has helped ease the transition between training and the establishment of an independent career in hematology research by providing partial salary or other support during that critical period. - Chick-Fil-A: True Inspiration Awards
Amount: Up to $350,000
Deadline: Due May 1, 2025
Eligibility: —-
About: Award categories: Caring for People (four winners): Programs or projects supporting educational initiatives, including fostering character and leadership development, academic excellence and community involvement in underserved youth. Caring through Food (four winners): Programs or projects focused on addressing hunger and food insecurity facing children and their families. Caring for Communities (four winners): Programs or projects focused on providing housing and other direct services to support young people and their families. Caring for our Planet (four winners): Programs or projects that show care for our environment and our planet, or that demonstrate environmental stewardship through initiatives directly related to our other True Inspiration Awards categories of food, community and people (i.e., community beautification, education opportunities, community gardens, outdoor classrooms, etc.) Major Focus Areas: Pediatric Health; Pediatric Nutrition; Environmental Hazards (Nutrient Competitors) - ASH Bridge Grant
Amount: $150,000 over 1 years
Deadline: May 1, 2025
Eligibility: Have submitted to the NIH in the past 18 months a hematology-related R01 or R01-equivalent application that was scored but not funded. This includes investigators applying for their first R01. Please note: The 18-month timeframe begins the date your R01 was reviewed by the NIH study section. Be an ASH member in good standing and plan to maintain membership for the duration of the award term. Hold a faculty position at an academic institution or the equivalent position at a non-profit research organization. Employees of independent research institutions are eligible to apply if they have a faculty-type appointment and the institution is allowed to independently apply for and receive NIH funding. Have the commitment of his/her institution to match $50,000 in funds. At the time of award activation, have available no more than $250,000 annually in other research funding. This amount does not include the applicant’s salary/fringe or funding from within the institution.
About: Supports ASH members who applied for an NIH R01 grant or equivalent and were scored but not funded. ASH Bridge Grants are intended to help sustain recipients’ research and contribute to their retention in hematology investigation while they reapply. - International Anesthesia Research Society (IARS) Mentored Research Award
Amount: $175,000 over 2 years
Deadline: April 30, 2025
Eligibility: Principal applicant must be an IARS member. Principal applicant must be an investigator who has yet to establish substantial independent research funding or who is initiating a new area of research. Duration since completion of clinical training or PhD must be under 10 years. Applicants must have a minimum of 45% protected non-clinical time. Prior or current recipients of NIH R grants, NIH K grants, AHA Young Investigator Awards, VA Career Development Awards, or the equivalent, are not eligible to apply. IMRA recipients may not be simultaneously receiving support from an NIH T32 grant. IARS does not allow for concurrent funding of an IMRA with these or similar awards. Prior or current recipients of Foundation for Anesthesia Education and Research (FAER) Mentored Research Training grants are not eligible to apply. Prior or current recipients of an individual award totaling more than $90,000/year are not eligible.
About: The IARS Mentored Research Awards (IMRA) are intended to support investigations that will further the understanding of clinical practice in anesthesiology and related sciences - Pulmonary Hypertension Association Health Disparities in PH Research Award
Amount: $100,000 over 2 year
Deadline: April 30, 2025
Eligibility: Applicants must have an advanced degree such as a PhD, MD, DO, PharmD or equivalent, or a doctoral-level clinical degree in public health, clinical health sciences, nursing, or allied health.
About: The purpose of the Pulmonary Hypertension Association’s Health Disparities in PH Research Award is to support research that addresses early diagnosis, education and improving clinical outcomes and treatments for people with pulmonary hypertension affected by health inequities. Proposals should identify and address factors that affect health inequities in vulnerable populations and clinical subsets of patients, or propose solutions to address areas of health disparities in PH. - Elsa U. Pardee Foundation: Research Grants
Amount: Unspecified (~$200,000) over 1 year
Deadline: April 30, 2025
Eligibility: Post-docs who are on the tenure track and have a tenured mentor are eligible. Priority is given to researchers at non-profit institutions in the United States who are new to the field of cancer research, or to established research investigators examining new approaches to cancer cure.
About: The Foundation supports projects for a one-year period which will allow the establishment of capabilities of new cancer researchers or new cancer approaches by established cancer researchers. It is anticipated that this early-stage funding by the Foundation may lead to subsequent and expanded support using government agency funding. Project relevance to cancer detection, treatment, or cure should be clearly identified. By design, there are no limits set on the grant amount that can be requested. - Children’s Cancer Research Fund: Childhood Cancer Survivorship Research Award
Amount: Up to $250,000 over 2y
Deadline: LOI Due April 29, 2025
Eligibility: Proposals to develop drugs or modalities meant to mitigate late effects, as the sole or primary focus, are eligible. Proposals to develop therapeutic approaches (new drugs, modalities, or regimens for treating cancer) are not eligible to apply. We will accept applications that are new or from a previous pilot study, and applications (R03, R21) that have been reviewed but not funded by National Institutes of Health (NIH). Applicants must be PI-eligible at their sponsoring institution
About: Supports projects that focus on improving the quality and quantity of life for childhood, adolescent and young adult cancer survivors. Our goal is to support development of interventions that prevent, minimize and address the late effects of cancer therapies. Projects that propose to translate basic research into interventions, regardless of whether these take place during active therapy or later, are encouraged. Observational studies are welcome but are a lower priority, except those describing late effects (or early signs of late effects) among children receiving novel agents or therapies. - Children’s Cancer Research Fund: Eliminating Disparities in Childhood Cancer Award
Amount: Up to $250,000 over 2y
Deadline: LOI Due April 29, 2025
Eligibility: We will accept applications that are new or from a previous pilot study, and applications (R03, R21) that have been reviewed but not funded by National Institutes of Health (NIH). Applicants must be PI-eligible at their sponsoring institution. Awardees are required to commit at least 10 percent of their research effort each year to activities supported by this award
About: Supports projects that reduce health disparities or inequities in childhood cancer incidence, presentation, access to care, outcome of therapy including adverse event rates, or survivorship. Proposals that identify modifiable risk factors, elaborate mechanisms of disparities or inequities, or which plausibly propose to reduce them, will have greater priority for funding than proposals that simply describe them. - 2025 Innovative Tinnitus Research Grants Program
Amount: Early Investigators: Up to $50,000 over 2 years; Established Investigators: Up to $120,000 over 2 years
Deadline: April 25, 2025
Eligibility: Applications are open to all researchers, regardless of career stage or international status.
About: American Tinnitus Association (ATA) is pleased to support innovative tinnitus research proposals. ATA Grants support one- or two-year investigations aimed at contributing substantively to the scientific understanding of tinnitus and improving the patient care and quality-of-life for those affected by tinnitus. ATA seed grants support novel ideas, including fundamental and clinical research, to advance understanding of tinnitus, its treatment, and possible cure/s. ATA seed grants enable the Principal Investigator (PI) to obtain quality data that can be used to seek further funding from larger institutions, such as the NIH and DoD. - Burroughs Wellcome Fund: Climate Change and Human Health Seed Grants
Amount: $50,000 over 1 years
Deadline: April 24, 2025
Eligibility: Applicant organizations may submit multiple proposals, but an individual may only serve as a principal investigator/project director on one application during each review period. This call focuses on developing partnerships. Proposals from single institutions must develop partnerships that do not already occur naturally: for example, proposals from departments that draw students from the same shared graduate program are not responsive to this call. Proposals from more than one institution are responsive. This program does not support biomedical research projects proposed by individual investigators, but only by collaborative teams. Eligible proposals will include rationale/vision for the project, including who it is intended to impact. Individuals may only serve twice as directors (principal investigators/project directors) for proposals supported over time by this program. Current and past awardees from other BWF programs are eligible to apply.
About: Supports new connections between thinkers working in largely disconnected fields who might together change the course of climate change’s impact on human health. Funding priorities include activities that build connections between basic/early biomedical scientific approaches and ecological, environmental, geological, geographic, and planetary-scale thinking, as well as with population-focused fields including epidemiology and public health, demography, economics, and urban planning. Also of interest is work piloting new approaches or new interactions toward reducing the impact of health-centered activities, for example, developing more sustainable systems for health care, care delivery, and biomedical research systems. - Mother Cabrini Health Foundation 2025 Grants
Amount: No set Budget
Deadline: LOI due April 24, 2025
Eligibility: —
About: Mother Cabrini supports projects benefitting benefit poor, disadvantaged, or underserved New York State residents in the following funding mechanisms: Access to Healthcare; Basic Needs; Healthcare Workforce; Mental and Behavioral Health; General Fund - AACR-EXELIXIS Renal Cell Carcinoma Research Fellowship
Amount: $130,000 over 2 years
Deadline: April 23, 2025
Eligibility: Applicants must have a doctoral degree (including PhD, MD, MD/PhD, or equivalent) in a related field and not currently be a candidate for a further doctoral degree. At the start of the grant term on August 1, 2024, applicants must: Hold a mentored research position with the title of postdoctoral fellow, clinical research fellow, or the equivalent; If eligibility is based on a future position, the position must be confirmed at the time of submission, and CANNOT be contingent upon receiving this grant. If the future position is at a different institution than the applicant’s current institution, the applicant must contact AACR’s Research and Grants Administration Department (AACR’s RGA) at grants@aacr.org before submitting their application for information on additional verification materials/signatures that may be required. Have completed their most recent doctoral degree within the past five years (i.e., degree cannot have been conferred before August 1, 2019; the formal date of receipt of doctoral degree is the date the degree was conferred, as indicated on your diploma and/or transcript). Applicants with a medical degree must have completed their most recent doctoral degree or medical residency – whichever date is later – within the past five years. Work under the auspices of a mentor at an academic, medical, or research institution anywhere in the world.
About: Supports a postdoctoral or clinical research fellow to conduct renal cell carcinoma research and to establish a successful career path in this field. The research proposed for funding may be in basic, translational, clinical, or population sciences research and must have direct applicability and relevance to renal cell carcinoma. - AACR-ASTRAZENECA Endometrial Cancer Research Fellowship
Amount: $130,000 over 2 years
Deadline: April 22, 2025
Eligibility: Hold a mentored research position with the title of postdoctoral fellow, clinical research fellow, or the equivalent. Have completed their most recent doctoral degree within the past five years.
About: Supports postdoctoral or clinical research fellows to conduct endometrial cancer research and to establish a successful career path in this field. The research proposed for funding must have direct applicability to endometrial cancer and may involve basic, translational, clinical, or population sciences research. - Pfizer: Advances in Migraine Management
Amount: $200,000 over 2 years
Deadline: April 21, 2025
Eligibility: —
About: This competitive program seeks to encourage organizations to submit grant applications for educational activities focused on healthcare professionals involved in the management and care of people with migraine. - American Medical Association: Transforming Lifelong Learning Through Precision Education
Amount: $1,100,000 over 4 years
Deadline: LOI due April 21, 2025
Eligibility: —
About: Precision education systems in medicine use data and technology to transform lifelong learning from medical school to practice by improving personalization, efficiency, and agency at the individual, program, and organizational levels. Ultimately, these systems tighten the alignment between learning and practice, with the aim of improving patient outcomes. This builds on the work of the Accelerating Change in Medical Education and Reimagining Residency initiatives to redesign training around the needs of patients and communities. - Orphan Disease Center Jack Bear Foundation Grant Program 2025
Amount: $100,000 over 1 years
Deadline: April 18, 2025
Eligibility: We welcome applications from tenure-track faculty, non-tenure-track faculty and postdoctoral (PhD or MD) fellows; applications submitted by postdoctoral fellows must include a statement of feasibility and support from their faculty mentor. This opportunity is open to investigators at established academic and research institutions worldwide. We also welcome applications from individuals in a senior position at a non-profit institution or foundation. Collaboration with existing SCAR-15 researchers is encouraged but not required.
About: The Jack Bear Foundation, in collaboration with the Orphan Disease Center, will provide a 1- year grant to support several critical components of basic, clinical and translational research on disorders associated with genetic mutations in the RUBCN gene with a particular emphasis on the topics outlined below: Basic understanding of canonical and noncanonical functions of SCAR-15 disease associated with the RUBCN gene; Identification of biomarkers for RUBCN gene/SCAR-15 disease using patient samples; Development and characterization of patient-derived cell models of SCAR-15 disease (ex. iPSCs, neurons, reporter lines); Development and phenotypic characterization of animal models with the RUBCN gene/SCAR-15 disease; Development of a standardized evaluation criteria for clinical projects allowing uniformity of patients as well as the severity and progression of the disease. Support small animal studies or assays that investigate drug repurposing strategies. - Borealis Philanthropy: Fund for Trans Generations
Amount: $600,000
Deadline: Rolling
Eligibility: Organization or project must be trans-led. We adhere to the Trans Justice Funding Project definition, which holds that the majority of the people in charge of the group identify as trans or gender non-conforming. “In charge” includes any of the following examples: The director, if there is one, should identify as trans or gender non-conforming.; The majority of the governing board collective, advisory committee, or similar governing body, if there is such a body, should identify as trans or gender non- conforming.; The majority of any staff members should identify as trans or gender non- conforming.; If the organization or project is volunteer-run, the majority of volunteers should identify as trans or gender non-conforming.
About: We will prioritize supporting organizations and fiscally sponsored projects based in trans communities that are facing high levels of harm and who have limited access to foundation support. Request examples may include the following: Communications, advocacy, and organizing trainings to defeat anti-trans legislation; Direct actions that confront transphobic legislation, attempts to dismantle trans protections, or other activities aimed at harming trans communities.; Travel support for a timely trans convening or training opportunity; A new project or network that is doing proactive movement-building work and needs support to lay the groundwork for this - The Cardiovascular Medical Research and Education Fund: Research Projects
Amount: $100,000 over 2 year
Deadline: Rolling
Eligibility: —
About: The CMREF does not have a formal application process to fund clinical research or educational projects but is always interested in potentially providing full or partial support to initiatives that are novel, innovative, or address the spectrum of unmet medical needs related to pulmonary vascular diseases. Interested parties should submit a Letter of Intent (maximum of two pages) that describes the project sufficiently so that the Research Advisory Committee can understand the proposed goals and methods.